Literature DB >> 28245140

Correlation of Lung Clearance Index with Hyperpolarized 129Xe Magnetic Resonance Imaging in Pediatric Subjects with Cystic Fibrosis.

Nikhil Kanhere1, Marcus J Couch1, Krzysztof Kowalik1, Brandon Zanette1,2, Jonathan H Rayment1, David Manson1,2, Padma Subbarao1,2, Felix Ratjen1,2, Giles Santyr1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28245140     DOI： 10.1164/rccm.201611-2228LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  12 in total

1.  Longitudinal Assessment of Children with Mild Cystic Fibrosis Using Hyperpolarized Gas Lung Magnetic Resonance Imaging and Lung Clearance Index.

Authors:  Laurie Smith; Helen Marshall; Ina Aldag; Felix Horn; Guilhem Collier; David Hughes; Noreen West; Alex Horsley; Chris J Taylor; Jim Wild
Journal:  Am J Respir Crit Care Med       Date:  2018-02-01       Impact factor: 21.405

2.  A two-center analysis of hyperpolarized 129Xe lung MRI in stable pediatric cystic fibrosis: Potential as a biomarker for multi-site trials.

Authors:  Marcus J Couch; Robert Thomen; Nikhil Kanhere; Raymond Hu; Felix Ratjen; Jason Woods; Giles Santyr
Journal:  J Cyst Fibros       Date:  2019-03-25       Impact factor: 5.482

3.  Xenon-129 MRI detects ventilation deficits in paediatric stem cell transplant patients unable to perform spirometry.

Authors:  Laura L Walkup; Kasiani Myers; Javier El-Bietar; Adam Nelson; Matthew M Willmering; Michael Grimley; Stella M Davies; Christopher Towe; Jason C Woods
Journal:  Eur Respir J       Date:  2019-05-02       Impact factor: 16.671

4.  New severity assessment in cystic fibrosis: signal intensity and lung volume compared to LCI and FEV1: preliminary results.

Authors:  Sabrina Fleischer; Mareen Sarah Kraus; Sergios Gatidis; Winfried Baden; Andreas Hector; Dominik Hartl; Ilias Tsiflikas; Juergen Frank Schaefer
Journal:  Eur Radiol       Date:  2019-11-14       Impact factor: 5.315

5.  Assessment of pulmonary structure-function relationships in young children and adolescents with cystic fibrosis by multivolume proton-MRI and CT.

Authors:  Francesca Pennati; David J Roach; John P Clancy; Alan S Brody; Robert J Fleck; Andrea Aliverti; Jason C Woods
Journal:  J Magn Reson Imaging       Date:  2018-02-19       Impact factor: 4.813

Review 6.  Current state of the art MRI for the longitudinal assessment of cystic fibrosis.

Authors:  Jason C Woods; Jim M Wild; Mark O Wielpütz; John P Clancy; Hiroto Hatabu; Hans-Ulrich Kauczor; Edwin J R van Beek; Talissa A Altes
Journal:  J Magn Reson Imaging       Date:  2019-12-17       Impact factor: 4.813

7.  Imaging Lung Function Abnormalities in Primary Ciliary Dyskinesia Using Hyperpolarized Gas Ventilation MRI.

Authors:  Laurie J Smith; Noreen West; David Hughes; Helen Marshall; Christopher S Johns; Neil J Stewart; Ho-Fung Chan; Madhwesha Rao; David J Capener; Jody Bray; Guilhem J Collier; Paul J C Hughes; Graham Norquay; Lynne Schofield; Phil Chetcuti; Eduardo Moya; Jim M Wild
Journal:  Ann Am Thorac Soc       Date:  2018-12

Review 8.  Novel imaging techniques for cystic fibrosis lung disease.

Authors:  Jennifer L Goralski; Neil J Stewart; Jason C Woods
Journal:  Pediatr Pulmonol       Date:  2021-02

9.  Neonatal Pulmonary Magnetic Resonance Imaging of Bronchopulmonary Dysplasia Predicts Short-Term Clinical Outcomes.

Authors:  Nara S Higano; David R Spielberg; Robert J Fleck; Andrew H Schapiro; Laura L Walkup; Andrew D Hahn; Jean A Tkach; Paul S Kingma; Stephanie L Merhar; Sean B Fain; Jason C Woods
Journal:  Am J Respir Crit Care Med       Date:  2018-11-15       Impact factor: 30.528

10.  Comparison of single breath hyperpolarized 129 Xe MRI with dynamic 19 F MRI in cystic fibrosis lung disease.

Authors:  Andrew McCallister; Sang Hun Chung; Michael Antonacci; Margret Z Powell; Agathe S Ceppe; Scott H Donaldson; Yueh Z Lee; Rosa Tamara Branca; Jennifer L Goralski
Journal:  Magn Reson Med       Date:  2020-08-08       Impact factor: 4.668
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.